1-3 of 3
Eduard H Panosyan, MD
Close
Sort by
Journal Articles

Pediatric Patients with Sickle Cell Disease at Harbor-UCLA & Early Experience of L-Glutamine Therapy

Moran Gotesman, MD, Guy Elgar, BS, Youngju Pak, PhD, Laura Hernandez Santiago, BS, Abigail Alvarez, PNP, Henry Lin, MD, Joseph L Lasky, III, MD, Eduard H. Panosyan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6.
https://doi.org/10.1182/blood-2020-137280
Published: 2020
Journal Articles

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Yutaka Niihara, MD, Charles William Stark, PharmD, Rafael Razon, MD, Lan T Tran, MPH, Joseph M Becerra, PharmD, Eduard H. Panosyan, MD, Joseph Louis Lasky, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1065.
https://doi.org/10.1182/blood-2018-99-119720
Published: 2018
Journal Articles

Adverse Reactions to PEG and Erwinia Asparaginase and Correlation with Anti-Asparaginase Antibody Data and Survival in Children with Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group Study CCG 1961.

Girish Dhall, M.D., Tamekia Jones, PhD, David Radvinsky, Nathan Robison, MD, Anna Butturini, MD, Joan I Rubin, RN, Paul S. Gaynon, MD, Eduard H Panosyan, MD, Ioannis A Avramis, Vassilios I Avramis, PhD, Lawrence J. Ettinger, MD, Nita L. Seibel, MD
Journal: Blood
Blood (2009) 114 (22): 3077.
https://doi.org/10.1182/blood.V114.22.3077.3077
Published: 2009